GEN Exclusives

More »

Feature Articles

More »
Sep 1, 2009 (Vol. 29, No. 15)

Q&A on Sartorius Stedim Biotech/SAFC Deal

Looking at the Rationale for the Agreement and What the Two Companies Plan to Offer

  • Click Image To Enlarge +
    Maik Jornitz

    SAFC Biosciences and Sartorius Stedim Biotech recently signed a global partnership agreement that combines Sartorius Stedim Biotech’s expertise in filtration and liquid-handling systems with SAFC Biosciences’ proficiency in development and manufacturing of cell culture media and downstream purification products.

    The companies will combine their expertise in generating application data on filter and mixing performance with critical purification buffers and cell culture media. Similarly, extractable and leachable data will be generated with buffers and media, and with filters and biobag combinations.

    In addition, SAFC expects to utilize Sartorius Stedim Biotech’s technology for storage and mixing of cell culture media to optimize its fluid/powder handling system.

    To obtain a further perspective on the agreement, GEN interviewed Maik Jornitz, group vp, product management, filtration/ fermentation technologies at Sartorius Stedim Biotech, and Bruce Lehr, director of marketing at SAFC Biosciences.

  • Click Image To Enlarge +
    Bruce Lehr

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?